MRI utilization in newly diagnosed breast cancer: A survey of practicing surgeons

Annals of Surgical Oncology

Volumn 20, Issue 8, 2013, Pages 2600-2606

  Parker, Anna ^a   Schroen, Anneke T ^a   Brenin, David R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CLINICAL PRACTICE; FAMILY HISTORY; HEALTH SURVEY; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PRIVATE PRACTICE; SPECIALIZATION; SURGEON;

BREAST NEOPLASMS; CARCINOMA; CHI-SQUARE DISTRIBUTION; DATA COLLECTION; FEMALE; HUMANS; INSTITUTIONAL PRACTICE; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MAMMARY GLANDS, HUMAN; PHYSICIAN'S PRACTICE PATTERNS; PRIVATE PRACTICE; SPECIALIZATION;

EID: 84880322158     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2934-5     Document Type: Article

References (33)

1. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
2. SEER Cancer Statistics Review, 1975-2008. http://seer.cancer.gov/csr/ 1975-2008. Accessed 19 Mar 2013.
3. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427-37.
4. Kriege M, Brekelmans CT, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, et al. Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat. 2006;100:109-19.
5. Davis PL, McCarty KS, Jr. Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol. 1997;7 Suppl 5:289-98.
6. Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209:180-7; quiz 294-5.
7. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248-58.
8. ACS Cancer Facts and Figures 2013. www.cancer.org/Research/ CancerFactsFigures. Accessed 19 Mar 2013.
9. Woodward C, Chambers L. Guide to questionnaire construction and question writing, 3rd ed. Ottawa: Canadian Public Health Association, 1986.
10. Dillman D. Mail and internet surveys: the tailored design method. New York: Wiley, 2000.
11. Sommer CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS. Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res. 2011;170:77-83.
12. Hwang N, Schiller DE, Crystal P, Maki E, McCready DR. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol. 2009;16:3000-9.
13. Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563-71.
14. Peters NH, van Esser S, van den Bosch MA, Storm RK, Plaisier PW, van Dalen T, et al. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer. 2011;47:879-86.
15. Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin. 2009;59:290-302.
16. Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386-91.
17. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. 2010;102:1224-37.
18. Dillon MF, Hill AD, Fleming FJ, O'Doherty A, Quinn CM, McDermott EW, et al. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma. Am J Surg. 2006;191:201-5.
19. Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat. 2008;107:1-14.
20. Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-20.
21. Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Cancer. 2005;103:2447-54.
22. McGhan LJ, Wasif N, Gray RJ, Giurescu ME, Pizzitola VJ, Lorans R, et al. Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol. 2010;17 Suppl 3:255-62.
23. Mann RM, Loo CE, Wobbes T, Bult P, Barentsz JO, Gilhuijs KG, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2010;119:415-22.
24. Heywang SH, Fenzl G, Hahn D, Krischke I, Edmaier M, Eiermann W, et al. MR imaging of the breast: comparison with mammography and ultrasound. J Comput Assist Tomogr. 1986;10:615-20.
25. Heywang SH, Hahn D, Schmidt H, Krischke I, Eiermann W, Bassermann R, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr. 1986;10:199-204.
26. Kaiser WA. MRM promises earlier breast cancer diagnosis. Diagn Imaging (San Franc). 1992;14:88-93.
27. Gilles R, Guinebretiere JM, Lucidarme O, Cluzel P, Janaud G, Finet JF, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology. 1994;191:625-31.
28. Kuhl CK, Mielcareck P, Klaschik S, Leutner C, Wardelmann E, Gieseke J, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology. 1999;211:101-10.
29. Bassett LW, Dhaliwal SG, Eradat J, Khan O, Farria DF, Brenner RJ, et al. National trends and practices in breast MRI. AJR Am J Roentgenol. 2008;191:332-9.
30. Barringer B. University of Virginia Health System Dept of Revenue Cycle. Personal communication, September, 2011.
31. Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res. 2009;9:9.
32. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129-36.
33. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86:628-37.